A bit more about diabetes and SADI:
http://www.soard.org/article/S1550-7289(15)00029-5/fulltext (this article has not yet been published, or is not available without a subscription - this is the abstract):
So, with the DS (as reported in the Frenken paper quoted in my earlier post:
SO:
- With DS, at 12 months out, 77% of people who had been insulin dependent for >10 years were no longer insulin dependent.
- With SADI at 12 months out, only 47% were in remission (and this study lumped together ALL of the people who were insulin dependent, not even distinguishing for how long!! - this includes people who only recently went on insulin!!) AND WORSE - the remission rate steadily decreased over time post-op with the SADI - by 5 years out, ONLY 38.4% were still in remission!! And that statistic may not even include ANY people with insulin dependent diabetes >10 years!
And the Pernaute SADIs have 200-250 cm alimentary tracts - you'll be getting a 300 cm one.
As Frenken says:
I would really really reconsider if I were you. You need to have the BEST chance of putting your diabetes in remission NOW.
And I'd demand an explanation of why Cottam thinks a SADI/SIPS/LDS is your BEST chance, based on the published data.
http://www.soard.org/article/S1550-7289(15)00029-5/fulltext (this article has not yet been published, or is not available without a subscription - this is the abstract):
Single-anastomosis duodenoileal bypass with sleeve gastrectomy (SADI-S) for obese diabetic patients
Correspondence
Received: October 25, 2014; Accepted: January 29, 2015; Published Online: February 05, 2015
- Correspondence: Andrés Sánchez-Pernaute, M.D., Ph.D., Chief, Esophago-gastric, obesity and metabolic surgery, Hospital Clínico San Carlos, c/Martín Lago s/n, 28040 – Madrid, Spain
Abstract
Background
Bariatric operations achieve a high remission rate of type 2 diabetes in patients with morbid obesity. Malabsorptive operations usually are followed by a higher rate of metabolic improvement, though complications and secondary effects of these operations are usually higher.
Objectives
Analyze the results of a simplified duodenal switch, the single-anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S) on patients with obesity and type 2 diabetes mellitus (T2 DM).
Setting
University Hospital, Madrid, Spain.
Methods
Ninety-seven T2 DM patients with a mean body mass index (BMI) of 44.3 kg/m2 were included. Mean preoperative glycated hemoglobin was 7.6%, and mean duration of the disease was 8.5 years. Forty patients were under insulin treatment. SADI-S was completed with a sleeve gastrectomy performed over a 54French bougie and a 200 cm common limb in 28 cases and 250 cm in 69.
Results
Follow up was possible for 86 patients (95.5%) in the first postoperative year, 74 (92.5%) in the second, 66 (91.6%) in the third, 46 (86.7%) in the fourth and 25 out of 32 (78%) in the fifht postoperative year. Mean glycemia and glycated hemoglobin decreased immediately. Control of the disease, with HbA1 c below 6%, was obtained in 70 to 84% in the long term, depending on the initial antidiabetic therapy. Most patients abandoned antidiabetic therapy after the operation. Absolute remission rate was higher for patients under oral therapy than for those under initial insulin therapy, 92.5% versus 47% in the first postoperative year, 96.4% versus 56% in the third and 75% versus 38.4% in the fifth. A short diabetes history and no need for insulin were related to a higher remission rate. Three patients had to be reoperated for recurrent hypoproteinemia.
Conclusion
SADI-S is an effective therapeutic option for obese patients with diabetes mellitus.
So, with the DS (as reported in the Frenken paper quoted in my earlier post:
3.3. Influence of Preoperative Duration of Insulin Therapy on
Postoperative Outcome. According to their need for insulin,
patients in group 3 were divided into 4 groups: 15 patients
were treated with oral antidiabetic medication, 25 used
insulin for less than 5 years, 23 used insulin for 5–10 years,
and 11 used insulin for more than 10 years. At discharge
from hospital, all patients in groups I and II were free of
insulin. Thirty-three percent of patients in group III, still
needed insulin at the time of discharge, but all of them were
free of insulin 12 months after the operation. In group IV,
73% needed insulin at the time of discharge, 23% still needed
small amounts of insulin 12 months after the operation
(Figure 4). HbA1c levels also decreased continuously in all
groups. Mean levels below 6% were reached 3 month after
surgery in groups I and II, 6 month after surgery in group III
and 2 years after surgery in group IV (Figure 5).
SO:
- With DS, at 12 months out, 77% of people who had been insulin dependent for >10 years were no longer insulin dependent.
- With SADI at 12 months out, only 47% were in remission (and this study lumped together ALL of the people who were insulin dependent, not even distinguishing for how long!! - this includes people who only recently went on insulin!!) AND WORSE - the remission rate steadily decreased over time post-op with the SADI - by 5 years out, ONLY 38.4% were still in remission!! And that statistic may not even include ANY people with insulin dependent diabetes >10 years!
And the Pernaute SADIs have 200-250 cm alimentary tracts - you'll be getting a 300 cm one.
As Frenken says:
As seen in bariatric surgery for morbid obesity, there will
not probably be only a single “anti-diabetic” operation but
several options, depending on the patients’ comorbidities,
weight, and, most likely, also duration and therapy of the
patients’ diabetes.
I would really really reconsider if I were you. You need to have the BEST chance of putting your diabetes in remission NOW.
And I'd demand an explanation of why Cottam thinks a SADI/SIPS/LDS is your BEST chance, based on the published data.